SI2215272T1 - Test skoraj popolnega genoma na odpornost proti hcv zdravilom - Google Patents

Test skoraj popolnega genoma na odpornost proti hcv zdravilom

Info

Publication number
SI2215272T1
SI2215272T1 SI200830251T SI200830251T SI2215272T1 SI 2215272 T1 SI2215272 T1 SI 2215272T1 SI 200830251 T SI200830251 T SI 200830251T SI 200830251 T SI200830251 T SI 200830251T SI 2215272 T1 SI2215272 T1 SI 2215272T1
Authority
SI
Slovenia
Prior art keywords
drug resistance
near full
hcv drug
genome assay
hcv
Prior art date
Application number
SI200830251T
Other languages
English (en)
Inventor
Gregoire Vuagniaux
Jean-Maurice Dumont
Joke Snoeck
Dooren Sonia Van
Anne-Mieke Vandamme
Original Assignee
Debiopharm Sa
Univ Leuven Kath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm Sa, Univ Leuven Kath filed Critical Debiopharm Sa
Publication of SI2215272T1 publication Critical patent/SI2215272T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/706Specific hybridization probes for hepatitis
    • C12Q1/707Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SI200830251T 2007-10-31 2008-10-31 Test skoraj popolnega genoma na odpornost proti hcv zdravilom SI2215272T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IB2007003304 2007-10-31
PCT/IB2008/002924 WO2009056966A1 (en) 2007-10-31 2008-10-31 Near full-genome assay of hcv drug resistance
EP08844624A EP2215272B1 (en) 2007-10-31 2008-10-31 Near full-genome assay of hcv drug resistance

Publications (1)

Publication Number Publication Date
SI2215272T1 true SI2215272T1 (sl) 2011-08-31

Family

ID=40466927

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200830251T SI2215272T1 (sl) 2007-10-31 2008-10-31 Test skoraj popolnega genoma na odpornost proti hcv zdravilom

Country Status (17)

Country Link
US (2) US8911934B2 (sl)
EP (1) EP2215272B1 (sl)
JP (1) JP5607532B2 (sl)
AT (1) ATE499451T1 (sl)
AU (1) AU2008320529B2 (sl)
CA (1) CA2703765A1 (sl)
CY (1) CY1112482T1 (sl)
DE (1) DE602008005188D1 (sl)
DK (1) DK2215272T3 (sl)
ES (1) ES2361598T3 (sl)
HR (1) HRP20110347T1 (sl)
NZ (1) NZ585282A (sl)
PL (1) PL2215272T3 (sl)
PT (1) PT2215272E (sl)
RS (1) RS51849B (sl)
SI (1) SI2215272T1 (sl)
WO (1) WO2009056966A1 (sl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9528163B2 (en) 2011-06-20 2016-12-27 Siemens Healthcare Diagnostics Inc. Reagents and methods for detecting HCV
AU2013205064B2 (en) * 2012-06-04 2015-07-30 Gen-Probe Incorporated Compositions and Methods for Amplifying and Characterizing HCV Nucleic Acid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874565A (en) * 1995-08-29 1999-02-23 Washington University Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus
US7829693B2 (en) * 1999-11-24 2010-11-09 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of a target gene
US6368801B1 (en) * 2000-04-12 2002-04-09 Molecular Staging, Inc. Detection and amplification of RNA using target-mediated ligation of DNA by RNA ligase
CN1262672C (zh) * 2001-04-12 2006-07-05 株式会社生物核心 用于分析丙型肝炎病毒(hcv)基因型的寡核苷酸芯片组合物及其检测方法
EP2014671B1 (en) * 2002-03-11 2010-05-26 Lab 21 Limited Methods and compositions for identifying and characterizing hepatitis C
WO2009024834A2 (en) * 2006-12-05 2009-02-26 Rosetta Genomics Ltd Nucleic acids involved in viral infection
WO2009002918A2 (en) * 2007-06-22 2008-12-31 Nucleonics, Inc. Hepatitis c dsrna effector molecules, expression constructs, compositions, and methods of use

Also Published As

Publication number Publication date
HRP20110347T1 (hr) 2011-07-31
ATE499451T1 (de) 2011-03-15
AU2008320529A1 (en) 2009-05-07
JP5607532B2 (ja) 2014-10-15
RS51849B (en) 2012-02-29
US20140187765A1 (en) 2014-07-03
EP2215272A1 (en) 2010-08-11
US8911934B2 (en) 2014-12-16
DK2215272T3 (da) 2011-06-06
NZ585282A (en) 2012-03-30
PL2215272T3 (pl) 2011-08-31
WO2009056966A1 (en) 2009-05-07
EP2215272B1 (en) 2011-02-23
US20100311038A1 (en) 2010-12-09
ES2361598T3 (es) 2011-06-20
AU2008320529B2 (en) 2013-10-24
DE602008005188D1 (de) 2011-04-07
PT2215272E (pt) 2011-05-23
JP2011501957A (ja) 2011-01-20
CY1112482T1 (el) 2015-12-09
CA2703765A1 (en) 2009-05-07

Similar Documents

Publication Publication Date Title
HK1138297A1 (en) Human antibodies against hepatitis c virus (hcv) uses thereof (hcv)
CL2009000305A1 (es) Compuestos derivados de 2-aril-sustituido-1-benzofurano-3-carboxamida, inhibidores de la polimerasa ns5b; composicion farmaceutica; y su uso en el tratamiento de una enfermedad causada por el virus de la hepatitis c (hcv).
HK1126486A1 (en) Hepatitis c virus inhibitors (hcv)
GEP20104956B (en) Compounds for inhibiting hepatitis c viral replication and use thereof
ZA201003509B (en) Hepatitis c virus antibodies
SG2014012868A (en) Functional influenza virus like particles (vlps)
IL194920A0 (en) Hepatitis c virus infection biomarkers
PT2589602T (pt) Desenvolvimento de componentes de vacina contra o vírus da dengue
WO2009039246A3 (en) Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection
MX2010006313A (es) Inhibidores de la polimerasa virica.
IL200042A0 (en) Polypeptides and methods for the detection of influenza virus
EP2880030A4 (en) BRIDGED CYCLIC COMPOUNDS AS INHIBITORS OF HEPATITIS C VIRUS (HCV) AND THEIR PHARMACEUTICAL APPLICATIONS
ZA200907858B (en) Novel peptide inhibitors of hepatitis c virus replication
NZ593806A (en) Inhibitors of hcv ns5a
EP2217064A4 (en) NEW VACCINES AGAINST SEVERAL SUBTYPES OF THE INFLUENZAVIRUS
EP1761645A4 (en) DIAGNOSTIC PRIMERS AND METHOD FOR DETECTING H5 AND H5N1 SUBTYPES OF AVIAN INFLUENZA VIRUS
WO2007089618A3 (en) Hepatitis c serine protease inhibitors and uses therefor
EP2091960A4 (en) PEPTIDE VACCINE AGAINST INFLUENZA VIRUS
WO2006131936A3 (en) Hepatitis c virus vaccine
EP2205617A4 (en) SPECIFIC OLIGONUCLEOTIDE SEQUENCES OF HEPATITIS B VIRUS (HBV)
EP1871786A4 (en) PEPTIDE VACCINE AGAINST THE GRIPPEVIRUS
SI2215272T1 (sl) Test skoraj popolnega genoma na odpornost proti hcv zdravilom
MX2009003300A (es) Vectores de rhinovirus recombinantes.
EP1982728A4 (en) HEPATITIS C-VIRUS DERIVED PEPTIDE
CL2007001003A1 (es) Compuestos derivados de amidas; y uso en el tratamiento de un trastorno asociado con el virus de hepatitis c.